Product: CellChek20
Top Line: Konan Medical (Japan) and Konan Medical USA, makers of diagnostic devices for the ophthalmic industry, are launching their newest endothelial imaging system, CellChek 20.
Close Up: Specular microscopy from Konan Medical is widely regarded as the gold standard for cellular imaging and analytic assessment of the corneal endothelium. CellChek 20 adds a single-button press exam that acquires images of both eyes and the automated analysis with the new, fully-automated center method. CellChek 20 also features larger imaged area, superior image clarity as well as guttata recognition and redaction from cellular calculations.
“CellChek 20 offers a new level of convenience for our customers,” said Konan (Japan) CEO Tetsuji Ikegami. “Even during COVID, the interest has been particularly strong for high-tech, low-touch clinical specular microscopy found in CellChek 20.” Konan Medical USA CEO Charles Stewart added, “CellChek 20 has immediately generated a rebound in sales from customers and distributors. New analytic tools, compact package, and blazing fast, one-button for positioning, alignment, capture and analysis, for both eyes. The best specular product Konan has ever produced.” Click here to see a demonstration video of CellChek 20.
Vital Stats: CellChek 20 is FDA 510(k) cleared and CE marked.
Originally planned to be introduced at the world’s largest Ophthalmology meeting, the American Academy of Ophthalmology (AAO), Konan has made CellChek 20 available in Japan, Europe, North America and other regions through direct sales and distribution channels.;